Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IMNR - Immune Response -- Ignore unavailable to you. Want to Upgrade?

To: Emec who wrote (1013)	8/4/1998 3:23:00 PM
From: billkirn	Read Replies (1) \| Respond to of 1510

IMNR action fits a pattern these days. Stock gets visibility, news and potential is very positive. Stock rises as public buys into the speculation and excitement. BOOM! The shorts start buying. Stock drifts down to below where it began. This behavior is particularly attractive for Biotechs since the time line from news to results is very long and many things can side track their ability to execute. Probably could play this type of behavior and make some money. It really seems traders are jumping on these puppies. Bill